Albireo Pharma Inc. (NASDAQ: ALBO) stock closed at 44.15 per share at the end of the most recent trading day (a -0.23% change compared to the prior day closing price) with a volume of 1.24M shares and market capitalization of 915.85M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 90 people. Albireo Pharma Inc. CEO is Ronald H.W. Cooper.

The one-year performance of Albireo Pharma Inc. stock is 64.99%, while year-to-date (YTD) performance is 104.3%. ALBO stock has a five-year performance of 35.55%. Its 52-week range is between 16.02 and 45.23, which gives ALBO stock a 52-week price range ratio of %

Albireo Pharma Inc. currently has a PE ratio of -3.40, a price-to-book (PB) ratio of 4.72, a price-to-sale (PS) ratio of 36.50, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -45.83%, a ROC of -84.98% and a ROE of -103.26%. The company’s profit margin is -80.90%, its EBITDA margin is -214.50%, and its revenue ttm is $24.87 Million , which makes it $1.20 revenue per share.

Of the last four earnings reports from Albireo Pharma Inc., there were 1 positive earnings surprise and 3 negative earnings surprise. The company has EPS estimate of $-1.80 for the next earnings report. Albireo Pharma Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Albireo Pharma Inc. is Moderate Buy (2.43), with a target price of $58, which is 0.00% compared to the current price. The earnings rating for Albireo Pharma Inc. stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Albireo Pharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Albireo Pharma Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 13.79, ATR14 : 0.67, CCI20 : 40.16, Chaikin Money Flow : -0.19, MACD : 1.28, Money Flow Index : 21.90, ROC : -0.09, RSI : 68.04, STOCH (14,3) : 52.98, STOCH RSI : 0.05, UO : 45.73, Williams %R : -47.02), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Albireo Pharma Inc. in the last 12-months were: Jan P. Mattsson (Sold 3 892 shares of value $159 481 ), Jason G. Duncan (Sold 3 134 shares of value $101 591 ), Martha Carter (Sold 1 371 shares of value $54 481 ), Michelle Graham (Sold 2 189 shares of value $90 396 ), Pamela Stephenson (Sold 3 564 shares of value $116 947 ), Ronald H.W. Cooper (Sold 3 812 shares of value $117 241 ), Simon Nicolas Reade Harford (Sold 2 462 shares of value $97 916 )